Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shuhaihua (Beijing) Biotechnology is a specialized biotech company focused on the development of organ-on-a-chip technology and high-throughput drug screening solutions. The company leverages microfluidics and advanced biomaterials to create bionic organ models that simulate the microenvironment of human tissues, such as the liver, heart, and lungs. These models are utilized for drug metabolism, toxicity assessment, and efficacy screening, providing a more predictive alternative to animal models. Shuhaihua serves pharmaceutical companies and academic researchers by offering both standardized chip products and customized contract research services. Their mission is to enhance the efficiency of the drug development process through innovative in vitro modeling. The company is recognized as a leader in the Chinese microfluidic biosensor and organ-on-a-chip sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shu Haihua.